Fresenius SE





Press Kit: Acquisition of APP Pharmaceuticals


September 30, 2008
Syndicated Credit Facilities for APP Pharmaceuticals acquisition financing increased by US$ 500 million due to strong demand

Documents:



September 10, 2008
Fresenius closes APP acquisition

Documents:



September 02, 2008
Fresenius and APP Pharmaceuticals Announce Clearance of APP Acquisition by U.S. Federal Trade Commission

Documents:



August 28, 2008
Moody’s confirms Fresenius SE’s Ba1 rating

Documents:



August 12, 2008
Fresenius SE successfully completes capital increase

Documents:



August 11, 2008
Fresenius resolves on capital increase

Documents:



August 11, 2008
Substantial oversubscription in first phase of syndication of US$ 2,400 million Senior Secured Credit Facilities

Documents:



July 17, 2008
Fresenius SE successfully executes offering of € 554 million mandatory exchangeable bonds, exchangeable into ordinary shares of Fresenius Medical Care

Documents:



July 17, 2008
Issuance of mandatory exchangeable bonds, exchangeable into ordinary shares of Fresenius Medical Care AG & Co. KGaA

Documents:



July 7, 2008
Fresenius Kabi to acquire APP Pharmaceuticals – entry into North American I.V. generics market provides excellent growth opportunities

Documents:


Press Conference:


Conference Call for analysts:

  • Presentation (PDF, 160 KB)
    Home  >  Press